Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ramipril 2.5mg/5ml oral liquid
0205051R0AAAFAF
|
Ramipril | Ramipril | Cardiovascular System | 5 |
|
Spironolactone 15mg/5ml oral suspension
0202030S0AADCDC
|
Spironolactone | Spironolactone | Cardiovascular System | 5 |
|
Zaroxolyn 5mg tablets
0202010V0BEABAA
|
Zaroxolyn | Metolazone | Cardiovascular System | 5 |
|
Zeyam 60mg modified-release tablets
0206020C0CBAAAA
|
Zeyam | Diltiazem hydrochloride | Cardiovascular System | 5 |
|
Arixtra 2.5mg/0.5ml inj pre-filled syringes
0208010ABBBAAAA
|
Arixtra | Fondaparinux sodium | Cardiovascular System | 4 |
|
Aspirin 75mg/5ml oral liquid
0209000A0AABGBG
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | 4 |
|
Cordarone X 200 tablets
0203020D0BBABAB
|
Cordarone X | Amiodarone hydrochloride | Cardiovascular System | 4 |
|
Entresto 6mg/6mg granules in capsules for opening
0205052AEBBADAD
|
Entresto | Sacubitril/valsartan | Cardiovascular System | 4 |
|
Fenofibrate 145mg / Simvastatin 20mg tablets
0212000AJAAAAAA
|
Fenofibrate/simvastatin | Fenofibrate/simvastatin | Cardiovascular System | 4 |
|
Furosemide 5mg/5ml oral solution sugar free
0202020L0AAATAT
|
Furosemide | Furosemide | Cardiovascular System | 4 |
|
Hydralazine 25mg/5ml oral liquid
0205010J0AAA8A8
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 4 |
|
Hydrochlorothiazide 12.5mg tablets
0202010L0AAAYAY
|
Hydrochlorothiazide | Hydrochlorothiazide | Cardiovascular System | 4 |
|
Hytrin tablets starter pack
0205040V0BBAEAA
|
Hytrin | Terazosin hydrochloride | Cardiovascular System | 4 |
|
Kenzem SR 60mg capsules
0206020C0BYAAAJ
|
Kenzem | Diltiazem hydrochloride | Cardiovascular System | 4 |
|
Lisoretic 20mg/12.5mg tablets
0205051K0BFAAAA
|
Lisoretic | Lisinopril with diuretic | Cardiovascular System | 4 |
|
Macitentan 10mg tablets
0205010AAAAAAAA
|
Macitentan | Macitentan | Cardiovascular System | 4 |
|
Metoprolol 5mg/5ml solution for injection ampoules
0204000K0AAAAAA
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 4 |
|
Monosorb XL 60 tablets (Almus)
0206010K0CCADAE
|
Monosorb | Isosorbide mononitrate | Cardiovascular System | 4 |
|
Nadolol 10mg/5ml oral liquid
0204000M0AAADAD
|
Nadolol | Nadolol | Cardiovascular System | 4 |
|
Namuscla 167mg capsules
0203020P0BCAAAN
|
Namuscla | Mexiletine hydrochloride | Cardiovascular System | 4 |
|
Ramipril 1.25mg/5ml oral liquid
0205051R0AAAGAG
|
Ramipril | Ramipril | Cardiovascular System | 4 |
|
Uard 180XL capsules
0206020C0BZACAV
|
Uard | Diltiazem hydrochloride | Cardiovascular System | 4 |
|
Urospir 25mg/5ml oral solution
0202030S0BKABEI
|
Urospir | Spironolactone | Cardiovascular System | 4 |
|
Ventavis 10micrograms/ml nebuliser solution 1ml ampoules
0205010V0BBAAAC
|
Ventavis | Iloprost | Cardiovascular System | 4 |
|
Verapamil 240mg modified-release capsules
0206020T0AAAKAK
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.